October 22-23, 2026

Lyon, France

COMMITTEES

SCIENTIFIC COMMITTEE

Bruno Lina

University Professor and Hospital Practitioner, Director

National Reference Center for respiratory infections virus, VirPath Laboratory, University Lyon 1

Derry Mercer

CEO

Bioscience Consultants

CSO

Selmod (part-time)

Support of Ventures

INCATE

Laure Delhon

Scientific Events Manager

MabDesign

Sandra Morel

Director, Vaccine Project Leader, Discovery Performance Unit

GSK

Daniel Larocque

Innovation Lead

Sanofi Vaccines

Robbert van der Most

Vice President Translational Science

VaxxCellence

Sherif Abouelhadid

Managing Director

BioDAR

Francesca Bernardini

VP In vitro Biology

Evotec

Lionel Cupillard

Executive Director Infectious Diseases

Boehringer Ingelheim Animal Health

Sotiris Missailidis

Head of Vaccine Innovation Development

Pasteur Institute

Dimitri Lavillette

Senior Researcher

CIRI Centre International de Recherche en Infectiologie

Clarisse Demont

Medical Advisor

Moderna

Sabine Leclercq

Founder

Leclercq Biopharma Consulting

Fabrice Porcheray

Head of Innovation

ANRS Maladies infectieuses émergentes

Florence Allantaz

Sr Director Innovation - Joint Units

bioMérieux

Nathalie Truchot-Limonne

Associate Director, Sr Principal Research Scientist - Safety Assessment

Charles River Laboratories

Bruno Versaevel

Head of the Healthcare Innovation, Technology & Society (HITS) Institute

emlyon HITS Institute